Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-219-4 | CAS number: 7790-75-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
No genetic toxicity study with calcium wolframate is available, thus the genetic toxicity will be addressed with existing data on the individual moieties calcium and wolframate.
Calcium wolframate is not expected to be genotoxic, since the two moieties calcium and wolframate have not shown gene mutation potential in bacteria.
Additional information
Read-across - calcium wolframate:
Calcium wolframate is the salt of wolframic acid. It is composed of calcium cations and wolframate anions so that calcium wolframate is electrically neutral (i.e. without a net charge). Any dissolution ofcalcium wolframatewill release the wolframate anion that is pH-dependent in equilibrium with undissociated wolframic acid (as based on the pKa of wolframic acid).
Thus, wolframate and wolframic acid, coexist in aqueous solution in adynamic pH-dependant equilibrium. Under neutral and basic conditions, the wolframate ion predominates whereas under more acidic conditions, the hydrogen wolframate anion and finally (below a pH of ca. 5) wolframic acid is more prevalent.
H2WO4 HWO4-+ H+ WO42-+ 2H+
The pKa values for wolframic acid is estimated to be 3.50 and 4.60 based on handbook data (Hollemann Wiberg, Lehrbuch der Anorganischen Chemie, 101.Auflage). The mean pKa value for calcium cations is estimated to be 12.6 based on handbook data (Lide, D.R., 2008).A Hägg-graph representing the equilibrium ofwolframic acid/ wolframateis provided below.
Due to its electronegativity E0(Ca/Ca2+) = -2,84V calcium is present in the environment only in the divalent cationic form. At high solution pH, i.e. above 12, calcium hydroxide complexes are formed.
Other calcium species, potentially relevant for the environmental of human health hazard assessment, are not present at environmentally or physiologically relevant redox conditions and solution pH.
According to the Hägg-graph and the Pourbaix- diagram wolframate is the dominant species under ENV conditions (Seiler et al., 2005). Anthropogenic use of W utilizes W metal or WC, which are thermodynamically unstable and when introduced into environmental systems begins to alter to a more stable form (WO42-) (Andersson and Bergstrom 2000).
Wolfram metal is (due to its negative potential (-0.09 to -1.074, pH0 -pH14)) transformed to wolframate which represents the most stable oxidation state of Wolfram(see Pourbaix Diagram below).
W + H2O/1.5 O2 --> 2 H++ WO42-
Hence, under physiological conditions wolframic acid, hydrogen wolframate and wolframate co-exist in a pH-dependent manner, irrespective of their origin.
Genetic toxicity in vitro - wolfram metal:
The substance should not be considered to have a mutagenic potential based on a bacterial reverse mutation assay (OECD 471). The substance does not require classification according to Regulation (EC) No 1272/2008 and subsequent adaptations.
Genetic toxicity in vitro - calcium ion:
Ribeiroet al.(2004) evaluated the genotoxic potential of calcium hydroxide using mouse lymphoma cells and human fibroblasts cells in vitro by the comet assay. Mouse lymphoma L5178Y cells were cultivated in suspension and human fibroblasts were gained from biopsy taken from human skin and cultured in DMEM medium supplemented with 20 % fetal calf serum. Calcium hydroxide was solved in distilled water and both cell lines treated with calcium hydroxide in three different concentrations (20, 40, 80 µg/mL). MMS served as positive control (10µg/mL). Cells were incubated for 1 hour and at the end of treatment period washed and resuspended with fresh medium. The comet assay was conducted according to the protocol published by Tice et al (2000). Two parameters were estimated: tail moment and tail intensity from 50 cells per treatment. Cell viability test for both cell lines was performed using trypan blue staining and treated cells were compared to untreated cells. At least 100 cells per group were counted. They reported that calcium hydroxide had no detectable genotoxic effect on both cell lines in three independent experiments. Compared to that the positive control induced a significant increase in tail moment and tail intensity. No significant differences in cellular viability in any of the treatment groups compared to untreated cells could be observed.
A further study also conducted by Ribeiroet al.(2005) evaluated the genotoxic potential of calcium hydroxide in Chinese hamster ovary (CHO) cells under the same conditions as already described above. CHO K-1 cells were cultured in Ham´s F-10 medium and seeded into 96-well microtiter plates. Ten microliters of the calcium hydroxide solution (100 µg/mL) were added to the CHO cells. MMS was used as positive control (1 µg/mL). Cells were incubated for 3 hours, washed and resuspended in fresh medium. The comet assay was conducted according to the protocol published by Tice et al (2000). Two parameters were estimated: tail moment and tail intensity from 50 cells per treatment group. The trypan blue test was also conducted to evaluate the cell viability. Data of three independent experiments showed that calcium hydroxide had no genotoxic or cytotoxic effect on CHO K-1 cells.
The Food and Drug Administration (FDA) evaluated the mutagenic potential of calcium phosphate and reported the results in their FDA report in 1975 (Report number RB-245-509). The FDA performed the bacterial reverse mutation test with the Salmonella typhimurium strains TA-1535, TA-1537 and TA-1538. All strains were tested in phosphate buffer for one hour at 37°C with a calcium phosphate concentration up to 0.75 % (50 % survival level) with and without metabolic activation. S9 was obtained from different animals and different tissues. Liver, lung and testes of male rats, mice and monkeys were used for the S9 preparation. Strain specific controls were included. All plates were incubated for four days and then scored. Each compound was done in duplicate. At a concentration of 0.75 % calcium phosphate was not mutagenic for any of the bacterial indicator strains with or without activation.
Justification for classification or non-classification
Calcium wolframate is not expected to be genotoxic, since the two moieties calcium and wolframate/wolfram metal have not shown gene mutation potential in bacteria. Thus, calcium wolframate is not to be classified according to regulation (EC) 1272/2008 as genetic toxicant.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.